162 related articles for article (PubMed ID: 35843949)
1. A pan-cancer analysis of thioredoxin-interacting protein as an immunological and prognostic biomarker.
Guo X; Huang M; Zhang H; Chen Q; Hu Y; Meng Y; Wu C; Tu C; Liu Y; Li A; Li Q; Zhou P; Liu S
Cancer Cell Int; 2022 Jul; 22(1):230. PubMed ID: 35843949
[TBL] [Abstract][Full Text] [Related]
2. Pan-Cancer Analysis of the N6-Methyladenosine Eraser FTO as a Potential Prognostic and Immunological Biomarker.
Zhao C; Liu Y; Ju S; Wang X
Int J Gen Med; 2021; 14():7411-7422. PubMed ID: 34744452
[TBL] [Abstract][Full Text] [Related]
3. Thioredoxin and thioredoxin-interacting protein as prognostic markers for gastric cancer recurrence.
Lim JY; Yoon SO; Hong SW; Kim JW; Choi SH; Cho JY
World J Gastroenterol; 2012 Oct; 18(39):5581-8. PubMed ID: 23112551
[TBL] [Abstract][Full Text] [Related]
4. ARPC2: A Pan-Cancer Prognostic and Immunological Biomarker That Promotes Hepatocellular Carcinoma Cell Proliferation and Invasion.
Huang S; Dong C; Li D; Xu Y; Wu J
Front Cell Dev Biol; 2022; 10():896080. PubMed ID: 35733852
[No Abstract] [Full Text] [Related]
5. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
6. A pan-cancer analysis confirms PTPN11's potential as a prognostic and immunological biomarker.
Cao Y; Duan H; Su A; Xu L; Lai B
Aging (Albany NY); 2022 Jul; 14(13):5590-5610. PubMed ID: 35802774
[TBL] [Abstract][Full Text] [Related]
7. Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker.
Cheng X; Wang X; Nie K; Cheng L; Zhang Z; Hu Y; Peng W
Front Immunol; 2021; 12():646523. PubMed ID: 33679809
[TBL] [Abstract][Full Text] [Related]
8. Pan-Cancer Analysis of FURIN as a Potential Prognostic and Immunological Biomarker.
Zhou B; Gao S
Front Mol Biosci; 2021; 8():648402. PubMed ID: 33968987
[TBL] [Abstract][Full Text] [Related]
9. Thioredoxin Interacting Protein (TXNIP) Is Differentially Expressed in Human Tumor Samples but Is Absent in Human Tumor Cell Line Xenografts: Implications for Its Use as an Immunosurveillance Marker.
Schröder J; Schumacher U; Böckelmann LC
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33081035
[TBL] [Abstract][Full Text] [Related]
10. HECT-Type Ubiquitin E3 Ligase ITCH Interacts With Thioredoxin-Interacting Protein and Ameliorates Reactive Oxygen Species-Induced Cardiotoxicity.
Otaki Y; Takahashi H; Watanabe T; Funayama A; Netsu S; Honda Y; Narumi T; Kadowaki S; Hasegawa H; Honda S; Arimoto T; Shishido T; Miyamoto T; Kamata H; Nakajima O; Kubota I
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26796253
[TBL] [Abstract][Full Text] [Related]
11. Role of thioredoxin reductase 1 and thioredoxin interacting protein in prognosis of breast cancer.
Cadenas C; Franckenstein D; Schmidt M; Gehrmann M; Hermes M; Geppert B; Schormann W; Maccoux LJ; Schug M; Schumann A; Wilhelm C; Freis E; Ickstadt K; Rahnenführer J; Baumbach JI; Sickmann A; Hengstler JG
Breast Cancer Res; 2010; 12(3):R44. PubMed ID: 20584310
[TBL] [Abstract][Full Text] [Related]
12. A pan-cancer analysis of the prognostic and immunological role of β-actin (ACTB) in human cancers.
Gu Y; Tang S; Wang Z; Cai L; Lian H; Shen Y; Zhou Y
Bioengineered; 2021 Dec; 12(1):6166-6185. PubMed ID: 34486492
[TBL] [Abstract][Full Text] [Related]
13. The landscape of prognostic and immunological role of myosin light chain 9 (MYL9) in human tumors.
Lv M; Luo L; Chen X
Immun Inflamm Dis; 2022 Feb; 10(2):241-254. PubMed ID: 34729929
[TBL] [Abstract][Full Text] [Related]
14. Pan-Cancer Analysis of PIMREG as a Biomarker for the Prognostic and Immunological Role.
Zhu H; Hu X; Ye Y; Jian Z; Zhong Y; Gu L; Xiong X
Front Genet; 2021; 12():687778. PubMed ID: 34594356
[TBL] [Abstract][Full Text] [Related]
15. Pan-Cancer Analyses Reveal Oncogenic and Immunological Role of PLOD2.
Xu Q; Kong N; Zhao Y; Wu Q; Wang X; Xun X; Gao P
Front Genet; 2022; 13():864655. PubMed ID: 35586565
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Prediction, Immune Microenvironment, and Drug Resistance Value of Collagen Type I Alpha 1 Chain: From Gastrointestinal Cancers to Pan-Cancer Analysis.
Liu Y; Xue J; Zhong M; Wang Z; Li J; Zhu Y
Front Mol Biosci; 2021; 8():692120. PubMed ID: 34395525
[No Abstract] [Full Text] [Related]
17. Thioredoxin/Txnip: redoxisome, as a redox switch for the pathogenesis of diseases.
Yoshihara E; Masaki S; Matsuo Y; Chen Z; Tian H; Yodoi J
Front Immunol; 2014 Jan; 4():514. PubMed ID: 24409188
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive pan-cancer analysis on CBX3 as a prognostic and immunological biomarker.
Niu H; Chen P; Fan L; Sun B
BMC Med Genomics; 2022 Feb; 15(1):29. PubMed ID: 35172803
[TBL] [Abstract][Full Text] [Related]
19. FAM65A as a novel prognostic biomarker in human tumors reveal by a pan-cancer analysis.
Liang W; Mo C; Wei J; Chen W; Gong W; Shi J; Hou X; Li C; Deng Y; Ou M
Discov Oncol; 2021 Dec; 12(1):60. PubMed ID: 35201499
[TBL] [Abstract][Full Text] [Related]
20. PRAME Is a Potential Carcinogenic Biomarker that Correlates with Patient Prognosis and Tumor Immunity Based on Pan-Cancer Analysis.
Zhao Q; Zhang Z; Wu Y
Ann Clin Lab Sci; 2022 Mar; 52(2):185-195. PubMed ID: 35414497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
